SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
Go back to SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma| Russell 2000 Low Beta ETF (NASDAQ: SLBT) | Delayed: 2.83 +0.16 (5.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.67 | 52 Week High | $53.95 | |||
| Open | $2.67 | 52 Week Low | $44.11 | |||
| Day High | $2.83 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $0.00 | |||
| Volume | 62,699 | |||||
